Jefferies analysts are optimistic about IBM's future after its Think 2026 conference, highlighting strong software pipeline trends and AI adoption potential. They see IBM as well-positioned in enterprise AI with a focus on infrastructure, regulated industries, and consulting-led AI deployment. Despite some short-term software delays due to hardware shortages, IBM's software pipeline is robust, with growth opportunities in platforms like HashiCorp and AI tools like the internal coding assistant 'Bob.' Jefferies maintains a $320 price target, noting IBM's valuation is currently below its historical average and peers. The firm also views IBM's mainframe business as a durable asset, supported by AI-driven demand and modernization efforts.
The global AI in life sciences market is projected to expand at a compound annual growth rate (CAGR) of about 20% from 2026 to 2034, reaching an estimated value of $11.5 billion. This growth is fueled by increasing demand for faster drug discovery, p...
The SPDR Russell 1000 Yield Focus ETF (ONEY) invests in large-cap U.S. stocks with high dividend yields combined with quality and low financial risk, including Johnson & Johnson, Procter & Gamble, Coca-Cola, and IBM. These companies have long histori...
IBM introduced two new managed services: Red Hat AI Inference on IBM Cloud and Red Hat OpenShift Virtualization Service on IBM Cloud. These services aim to help enterprises operationalize AI with real-time inferencing and securely migrate virtual mac...
